Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Medication Safety in Pregnancy and Breastfeeding

Medication Safety in Pregnancy and Breastfeeding

9780071448284
720,03 zł
684,03 zł Zniżka 36,00 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 684,03 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Publishers Note:: Products purchased from Third Party sellers are not guaranteed by the publisher for quality,  authenticity, or access to any online entitlements included with the product.


Fully understand the toxicological effects of prescription and OTC drugs on pregnant women and breastfed children

Drawn from the internationally recognized MotherRisk program at the University of Toronto, this authoritative resource is filled with evidence-based information and guidance that puts the risks of maternal exposure to drugs into sharp focus.

The books clear, easy-to-follow two-part organization conveniently reviews the toxicologic effects of all major drug classes, then provides well-researched, systematic reviews of major topics that impact pharmacotherapy in pregnant and breastfeeding patients. This complete guide is your best source of information-and, consequently, your patients best defense-against the possible ill effects of reproductive and developmental drug toxicities.

Features

  • The most authoritative resource available on the maternal toxicology of prescription drugs
  • Packed with evidence-based, systematic reviews of key maternal therapeutics and toxicology topics from leading peer-reviewed journals
  • Complete reviews of all major drug classes, and widely used agents-plus other herbal, chemical, and radiological therapies
  • Cutting-edge guidance from the world-renown MotherRisk program
  • Clear, conversational tone and cohesive two-part organization that facilitates your ability to quickly identify the risks associated with specific agents and communicate this crucial information to patients
  • And much more!
Szczegóły produktu
McGraw Hill / Medical
45392
9780071448284
9780071448284

Opis

Rok wydania
2007
Numer wydania
1
Oprawa
twarda
Liczba stron
864
Wymiary (mm)
218 x 279
Waga (g)
1520

  • Part I. RULES OF THUMB FOR TAKING DRUGS DURINGPREGNANCY AND BREASTFEEDING

    1. TAKING DRUGS DURING PREGNANCY: HOW SAFE ARE THE UNSAFE?
    Gideon Koren, MD, FRCPC, & Lavinia Schuler, MD

    2. WHICH DRUGS ARE CONTRAINDICATED DURING BREASTFEEDING?: PRACTICE GUIDELINES
    Myla E. Moretti, MSC, Amy Lee, MSC, Shinya Ito, MD,& Gideon Koren, MD

    3. CONTINUING DRUG THERAPY WHILE BREASTFEEDING: COMMON MISCONCEPTIONSOF PATIENTS
    Shinya Ito, MD, Mary Lieu, MSc, Williams Chan,& Gideon Koren, MD, FRCPC

    4. CONTINUING DRUG THERAPY WHILE BREASTFEEDING: COMMON MISCONCEPTIONSOF PHYSICIANS
    Gideon Koren, MD, FRCPC, Myla Moretti, MSC,& Shinya Ito, MD

    Part II. Drug Safety—A to Z

    5. DRUG SAFETY—A TO Z
    Gideon Koren, MD, FRCPC

    Part III. Selected Drugs, Chemicals, and Medical Conditions:Frequently Asked Questions with ConciseEvidence-Based Answers

    6. SAFE USE OF VALPROIC ACID DURING PREGNANCY
    Gideon Koren, MD, FRCPC, & Debbie Kennedy

    7. CANCER CHEMOTHERAPY DURING PREGNANCY: CONSORTIUM OF CANCERIN PREGNANCY EVIDENCE
    Michael Lishner, MD, & Gideon Koren, MD, FRCPC

    8. CORTICOSTEROIDS AND NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)DURING PREGNANCY
    Jochen G.W. Theis, MD, & Gideon Koren, MD

    9. MATERNAL OBESITY AND PRENATAL RISK
    Gideon Koren, MD, FRCPC

    10. ANTIHISTAMINES ARE APPARENTLY SAFE DURING THE FIRST TRIMESTER
    Gideon Koren, MD, FRCPC

    11. CAFFEINE DURING PREGNANCY?: IN MODERATION
    Gideon Koren, MD

    12. ANTIMALARIAL DRUGS FOR RHEUMATOID DISEASE DURING PREGNANCY
    Gideon Koren, MD

    13. NICOTINE REPLACEMENT THERAPY DURING PREGNANCY
    Gideon Koren, MD

    14. SAFETY OF COLCHICINE THERAPY DURING PREGNANCY
    Ran D. Goldman, MD, & Gideon Koren, MD, FRCPC

    15. USE OF WARFARIN DURING PREGNANCY
    Adrienne Einarson, RN, & RN Gideon Koren, MD, FRCPC

    16. CAN WE USE ANXIOLYTICS DURING PREGNANCY WITHOUT ANXIETY?: IN MODERATION
    Antonio Addis, PHARMD, Lisa R. Dolovich, PHARMD,Thomas R. Einarson, PHD, & Gideon Koren, MD, FRCPC

    17. NAUSEA AND VOMITING OF PREGNANCY: EVIDENCE-BASED TREATMENT ALGORITHM
    Carolyn Maltepe, Adrienne Einarson,& Gideon Koren, MD, FRCPC

    18. CAN HERBAL PRODUCTS BE USED SAFELY DURING PREGNANCY?
    Michael Gallo, & Gideon Koren, MD, FRCPC

    19. TAKING ACE INHIBITORS DURING PREGNANCY: IS IT SAFE?
    Savithiri Ratnapalan, MBBS, MRCP, & Gideon Koren, MD, FRCPC

    20. PROLONGED EXPOSURE TO ANGIOTENSIN-CONVERTING ENZYMEINHIBITORS DURING PREGNANCY.FETAL TOXICITY COULD BE REVERSIBLE
    A. Shrim, MD, & G. Koren, MD, FRCPC

    21. LOW-MOLECULAR-WEIGHT HEPARINS DURING PREGNANCY
    Ariel Many, MD, & Gideon Koren, MD, FRCPC

    22. DRINKING ALCOHOL WHILE BREASTFEEDING: WILL IT HARM MY BABY?
    Gideon Koren, MD, Myla Moretti, & Bhushan Kapur

    23. MULTIVITAMIN SUPPLEMENTS FOR PREGNANT WOMEN: NEW INSIGHTS
    Alejandro A. Nava-Ocampo, MD, MSC,& Gideon Koren, MD, FRCPC

    24. FOLIC ACID AND NEURAL TUBE DEFECTS: GOOD NEWS AT LAST!
    Gideon Koren, MD

    25. SAFETY OF GADOLINIUM DURING PREGNANCY
    Facundo Garcia-Bournissen, MD, Alon Shrim, MD,& Gideon Koren, MD, FRCPC

    26. TAKING GINGER FOR NAUSEA AND VOMITING DURING PREGNANCY
    Kiran Chandra, MSC, Adrienne Einarson, RN,& Gideon Koren MD, FRCPC

    27. OCCUPATIONAL EXPOSURE TO INHALED ANESTHETIC: IS IT A CONCERN FOR PREGNANTWOMEN?
    Samar Shuhaiber, & Gideon Koren, MD, FRCPC

    28. USING CORTICOSTEROIDS DURING PREGNANCY—ARE TOPICAL, INHALED,OR SYSTEMIC AGENTS ASSOCIATED WITH RISK?
    Dona Oren, MSC, Trena Nulman, MD ,Sh Ito, MD,& Gideon Koren, MD, FRCPC

    29. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR RHEUMATOID ARTHRITISDURING PREGNANCY
    Ana Florescu MSC, & Gideon Koren MD, FRCPC

    30. IS TOPICAL TRETINOIN SAFE DURING THE FIRST TRIMESTER?
    Lori Shapiro, MD, Giancarla Curto, MD,& Gideon Koren, MD, FRCPC

    31. HOW TO ENSURE FETAL SAFETY WHEN MOTHERS USE ISOTRETINOIN (ACCUTANE)
    Gideon Koren, MD, FRCPC

    32. YOUNG WOMEN TAKING ISOTRETINOIN STILL CONCEIVE: ROLE OF PHYSICIANSIN PREVENTING DISASTER
    Gideon Koren, MD, FRCPC

    33. HYPOTHYROIDISM DURING PREGNANCY
    Alejandro A. Nava-Ocampo, MD, MSC,Offie P. Soldin, PHD, MBA, & Gideon Koren, MD, FRCPC

    34. EFFECTS OF PRENATAL EXPOSURE TO MARIJUANA
    Eran Kozer, MD, & Gideon Koren, MD, FRCPC

    35. MARIJUANA USE AND BREASTFEEDING
    Josephine Djulus, MD, Myla Moretti, MSC,& Gideon Koren, MD, FRCPC

    36. METFORMIN USE DURING THE FIRST TRIMESTER OF PREGNANCY: IS IT SAFE?
    Gideon Koren, MD, FRCPC, Cameron Gilbert, MSC,& Maria Valois, MD, FRCPC

    37. IS THE FETUS SAFE WHEN SPERMICIDES FAIL?
    Gideon Koren, MD, FRCPC

    38. ACID-SUPPRESSING DRUGS DURING PREGNANCY
    Arieh Lalkin, MD, Laura Magee, MD, FRCPC,Antonio Addis, Pharmd, Ronen Loebstein, MD,& Gideon Koren, MD, FRCPC

    39. COUNSELING PREGNANT WOMEN WHO ARE TREATED WITH PAROXETINE
    Adrienne Einarson RN, & Gideon Koren MD, FRCPC

    40. DISCONTINUING ANTIDEPRESSANTS AND BENZODIAZEPINES UPON BECOMING PREGNANT
    Adrienne Einarson, RN, Peter Selby, MD,& Gideon Koren, MD, FRCPC

    41. RISKS OF UNTREATED DEPRESSION DURING PREGNANCY
    Adrienne Einarson, RN, & Gideon Koren, MD, FRCPC

    42. TAKING ANTIDEPRESSANTS DURING LATE PREGNANCY—HOW SHOULD WEADVISE WOMEN?
    Sanjog Kalra, MSc, Adrienne Einarson, RN,& Gideon Koren MD, FRCPC

    43. TAKING ST. JOHNS WORT DURING PREGNANCY
    Ran D. Goldman, MD, & Gideon Koren, MD, FRCPC

    44. TRIMETHOPRIM-SULFONAMIDE COMBINATION THERAPY IN EARLY PREGNANCY
    Anna Sivojelezova, Adrienne Einarson, RN,Samar Shuhaiber, MSC, & Gideon Koren, MD, FRCPC

    45. INFLUENZA VACCINATION DURING PREGNANCY
    Ran D. Goldman, MD, & Gideon Koren, MD, FRCPC

    46. ANTIRETROVIRAL TREATMENT OF MATERNAL HIV INFECTION
    Haleh Talaie MD, MPH, Alejandro A. Nava-Ocampo, MD,& Gideon Koren, MD, FRCPC

Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów